Immune responses in mice of β-galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres

Journal of Biomedical Materials Research - Part A

Volumn 73, Issue 3, 2005, Pages 332-338

  Stivaktakis, N ^a   Nikou, K ^a,b   Panagi, Z ^a   Beletsi, A ^a   Leondiadis, L ^b   Avgoustakis, K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

galactosidase; Adsorption; Encapsulation; Immunogenicity; Poly(lactic acid) (PLA) microspheres; Poly(lactic co glycolic acid) (PLGA) microspheres

Indexed keywords

ADSORPTION; ANTIBODIES; CARBOXYLIC ACIDS; ENZYME KINETICS; IMMUNOLOGY; PROTEINS;

ANTIBODY RESPONSE; GALACTOSIDASE; POLY(LACTIC ACID) (PLA); PROTEIN ENCAPSULATION;

IMMUNIZATION;

BETA GALACTOSIDASE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; MICROSPHERE; POLYGLACTIN; POLYLACTIC ACID;

ADSORPTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENCAPSULATION; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN;

ADSORPTION; ANIMALS; BETA-GALACTOSIDASE; BIOCOMPATIBLE MATERIALS; CYTOKINES; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; LACTIC ACID; MATERIALS TESTING; MICE; MICE, INBRED BALB C; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; T-LYMPHOCYTES;

EID: 18644365228     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30300     Document Type: Article

References (31)

1. O'Hagan DT, Jeffry H, Davis SS. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine 1993;11:965-969.
2. Men Y, Thomasin C, Merkle HP, Gander B, Corradin G. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine 1995;13:683-689.
3. Kersten GF, Donders D, Akkermans A, Beuvery EC. Single shot with tetanus toxoid in biodegradable microspheres protects mice despite acid-induced denaturation of the antigen. Vaccine 1996;14:1627-1632.
4. Men Y, Gander B, Merkle HP, Corradin G. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. Vaccine 1996;14:1442-1450.
5. Igartua M, Hernandez RM, Esquisabel A, Gascon AR, Calvo MB, Pedraz JL. Enhanced immune response after subcutaneous and oral immunization with biodegradable PLGA microspheres. J Controlled Release 1998;56:63-73.
6. Rosas JE, Pedraz JL, Hernandez RM, Gascon AR, Igartua M, Guzman F, Rodriguez R, Cortes J, Patarroyo ME. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunization of SPf66 encapsulated in PLGA microspheres. Vaccine 2002;20:1707-1710.
7. O'Hagan DT, Ott GS, Van Nest G. Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles. Mol Med Today 1997;3:69-75.
8. Lofthouse S. Immunological aspects of controlled antigen delivery. Adv Drug Delivery Rev 2002;54:863-870.
9. Eyles JE, Carpenter ZC, Alpar HO, Williamson ED. Immunological aspects of polymer microsphere vaccine delivery systems. J Drug Target 2003;11:509-514.
10. Alonso MJ, Gupta RK, Min C, Siber GR, Langer R. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems. Vaccine 1994;12:299-306.
11. Xing DKL, Crane DT, Bolgiano B, Corbel MJ, Jones C, Sesardic D. Physicochemical and immunological studies on the stability of free and microsphere-encapsulated tetanus toxoid in vitro. Vaccine 1996;14:1205-1213.
12. Morlock M, Koll H, Winter G, Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(D,L-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur J Pharm Biopharm 1997;43:29-36.
13. Sturesson C, Carlfors J. Incorporation of protein in PLG-microspheres with retention of bioactivity. J Controlled Release 2000;67:171-178.
14. Meinel L, Illi OE, Zapf J, Malfenti M, Merkle HP, Gander B. Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. J Controlled Release 2001;68:193-202.
15. Cleland JL, Jones AJS. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm Res 1996;13:1464-1474.
16. Van de Weert M, Hennink WE, Jiskoot W. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 1996;13:1464-1474.
17. Coombes AGA, Lavelle EC, Jenkins PG, Davis SS. Biodegradable lamellar particles of poly(lactide) induce sustained immune responses to a single dose of adsorbed protein. Vaccine 1999;17:2410-2422.
18. Kazzaz J, Neiderman J, Singh M, Ott G, O'Hagan DT. Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J Controlled Release 2000;67:347-356.
19. Singh M, Kazzaz J, Chesko J, Soenawan E, Ugozzou M, Giulliani M, Pizza M, Rappouli R, O'Hagan DT. Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B. J Pharm Sci 2004;93:273-282.
20. Nichtl A, Buchner J, Jaenicke R, Rudolph R, Scheibel T. Folding and association of β-galactosidase. J Mol Biol 1998;282:1083-1091.
21. Stivaktakis N, Nikou K, Panagi Z, Beletsi A, Leontiadis L, Avgoustakis K. PLA and PLGA microspheres of β-galactosidase: effect of formulation factors on protein antigenicity and immunogenicity. J Biomed Mater Res 2004;70A:139-148.
22. Beletsi A, Leontiadis L, Klepetsanis P, Ithakissios DS, Avgoustakis K. Effect of preparative variables on the properties of PLGA-mPEG copolymers related to their application in controlled drug delivery. Int J Pharm 1999;182:187-197.
23. Sah H. Stabilization of proteins against methylene chloride/ water interface-induced denaturation and aggregation. J Controlled Release 1999;58:143-151.
24. Coombes AGA, Lavelle EC, Jenkins PG, Davis SS. Single dose, polymeric microparticle based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen. Vaccine 1996;14:1429-1438.
25. Kreuter J, Liehl E, Berg U, Soliva M, Speiser PP. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants. Vaccine 1988;6:253-256.
26. Nixon DF, Hioe C, Chen P, Bian Z, Kuebler P, Li ML, Qiu H, Li XM, Singh M, Richardson J, MaGee P, Zamb T, Koff W, Wang CY, O'Hagan D. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine 1996;14:1523-1530.
27. Partidos CD, Vohra P, Jones D, Farrar G, Steward MW. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles. J Immunol Methods 1997;206:143-151.
28. Newman KD, Sosnowski DL, Kwon GS, Samuel J. Delivery of MUC1 mucin peptide by poly(D,L-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses. J Pharm Sci 1998;87:1421-1427.
29. Johansen P, Men Y, Merckle HP, Gander B. Revisiting PLA/ PLGA microspheres: an analysis of their potential in parenteral vaccination. Eur J Pharm Biopharm 2000;50:129-146.
30. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173.
31. Golding B, Scott DE. Vaccine strategies: targeting helper T cell responses. Ann NY Acad Sci 1995;754:126-137.